Thus, TREM2 appears to influence AD progression in a complex manner that may involve an initial beneficial impact related to the degradation of amyloid plaques and a subsequent detrimental impact linked to neuroinflammation. This evidence concerns the gene TREM2 and Alzheimer disease.